IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma
Zang, Rongyu1; Wu, Lingying1; Zhu, Jianqing1; Kong, Beihua1; Kim, Byoung-Gie1; Yao, Yuanquing1; Yin, Rutie1; Liu, Jihong1; Wu, Qiang1; Ngan, Hextan Yuen Sheung1; Xie, Xing1; Wang, Kung-Liahng1; Li, Xiuqin1; Yen, Ming-Shyen1; Wei, Lihui1; Wang, Qiong1; Mitrica, Ionel1; Carpenter, Christopher1; Zhang, Pingkuan1
刊名JOURNAL OF CLINICAL ONCOLOGY
2013-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000335419602026
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52391
专题北京大学第二临床医学院
作者单位1.Shanghai Fudan Univ, Shanghai, Peoples R China
2.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
3.Shandong Univ, Qi Lu Hosp, Jinan 250100, Peoples R China
4.Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China
5.Canc Hosp Jiangsu Prov, Nanjing, Jiangsu, Peoples R China
6.Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
7.Mackay Mem Hosp, Taipei, Taiwan
8.Taipei Vet Gen Hosp, Taipei, Taiwan
9.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
10.GlaxoSmithKline, Collegeville, PA USA
11.GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
12.GlaxoSmithKline, Shanghai, Peoples R China
13.Canc Hosp CAMS, Beijing, Peoples R China
14.PUMC, Beijing, Peoples R China
15.Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
16.Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
17.Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
18.Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China
19.China Med Univ, Shengjing Hosp, Huaxiang Branch, Shenyang, Peoples R China
推荐引用方式
GB/T 7714
Zang, Rongyu,Wu, Lingying,Zhu, Jianqing,et al. Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
APA Zang, Rongyu.,Wu, Lingying.,Zhu, Jianqing.,Kong, Beihua.,Kim, Byoung-Gie.,...&Zhang, Pingkuan.(2013).Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma.JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Zang, Rongyu,et al."Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zang, Rongyu]的文章
[Wu, Lingying]的文章
[Zhu, Jianqing]的文章
百度学术
百度学术中相似的文章
[Zang, Rongyu]的文章
[Wu, Lingying]的文章
[Zhu, Jianqing]的文章
必应学术
必应学术中相似的文章
[Zang, Rongyu]的文章
[Wu, Lingying]的文章
[Zhu, Jianqing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。